DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
202 hedge funds and large institutions have $2.22B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
3% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 64
Holders
202
Holding in Top 10
5
Calls
$10.7M
Puts
$8.22M
Top Buyers
| 1 | +$20.7M | |
| 2 | +$17M | |
| 3 | +$16.9M | |
| 4 |
JP Morgan Chase
New York
|
+$14.8M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$12.3M |
Top Sellers
| 1 | -$38.1M | |
| 2 | -$37M | |
| 3 | -$29M | |
| 4 |
Goldman Sachs
New York
|
-$17.1M |
| 5 |
State Street
Boston,
Massachusetts
|
-$17M |